2012
DOI: 10.4103/0255-0857.96695
|View full text |Cite
|
Sign up to set email alerts
|

Detection of bacterial growth in blood components using oxygen consumption as a surrogate marker in a tertiary oncology setup

Abstract: Microbiological contamination of blood and blood products is a well-recognised transfusion risk. This study was performed in the blood bank of our oncology centre, with an objective to detect bacterial contamination in our blood products using oxygen consumption as a surrogate marker [Pall Enhanced Bacterial Detection System (eBDS)]. Results revealed that the percentages of failed units were 1.16% for random donor platelets (RDP), 0.81% for single donor platelets (SDP) and 2.94% for packed red blood cells (PRB… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 11 publications
0
1
0
Order By: Relevance
“…Much effort has thus been devoted to the rapid and sensitive detection of bacterial pathogens in blood 18 21 . The enhanced bacterial detection (eBDS) system (Haemonetics Corporation, Braintree, MA, USA) indirectly detects bacteria by measuring decreases in oxygen concentration over 24 h, but cannot detect anaerobic bacteria 22 . The Platelet Pan-Genera Detection (PGD) test (Verax Biomedical, Marlborough, MA, USA) is a lateral flow immunoassay detecting lipoteichoic acid (LTA) and lipopolysaccharide (LPS) in aerobic and anaerobic Gram-positive and -negative bacterial species, respectively, within 30 min 23 .…”
Section: Introductionmentioning
confidence: 99%
“…Much effort has thus been devoted to the rapid and sensitive detection of bacterial pathogens in blood 18 21 . The enhanced bacterial detection (eBDS) system (Haemonetics Corporation, Braintree, MA, USA) indirectly detects bacteria by measuring decreases in oxygen concentration over 24 h, but cannot detect anaerobic bacteria 22 . The Platelet Pan-Genera Detection (PGD) test (Verax Biomedical, Marlborough, MA, USA) is a lateral flow immunoassay detecting lipoteichoic acid (LTA) and lipopolysaccharide (LPS) in aerobic and anaerobic Gram-positive and -negative bacterial species, respectively, within 30 min 23 .…”
Section: Introductionmentioning
confidence: 99%